The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

While there are therapies to aid in overall heart health, there are very few preventative therapies for heart failure after a significant heart attack, a serious condition that has a very significant ...

THE recent availability of pure L-nor-epinephrine (arterenol, nor-adrenaline) has permitted evaluation of its clinical usefulness as a pressor agent. Preliminary reports 1–7 have suggested beneficial ...

The world's first clinical trial to test glenzocimab as a potential new drug to improve the long-term outcomes for heart attack patients will take place in the UK. Glenzocimab is a humanised ...

Mitral-valve replacement was performed in five patients with ruptured papillary muscle secondary to myocardial infarction. In each case severe mitral regurgitation was suggested by the sudden ...

Myocardial infarction, or a heart attack, remains the most common cause of heart failure (HF) worldwide. Although there are treatments that aid in overall heart health, there are few preventative ...

This single-centre prospective study included 1,490 patients who had symptoms suggestive of ACS but without an ST elevation ...

Background Pericardium is considered electrically inert, but diffuse ST-elevation is an electrocardiographic marker of acute ...

A woman in her early 40s presented with an acute anterior ST-segment elevation myocardial infarction and new-onset atrial fibrillation (AF), 4 weeks after surgical resection of an incidental, ...